This site requires JavaScript and cookies to be enabled.
Tips for treatment success
Tips for treatment success
To make sure you’re getting the best results with Qelbree, it’s important that you take your medication as prescribed. Here you’ll find some ideas to help stay on track.
Medication-related tips
Try 90-day refills for convenience
Other tips
Navigating ADHD is a team effort
Join Qelbree Insider
Resources
Get the Qelbree Savings Card
*Terms and Conditions apply.
Starting doses and what to expect
Starting doses and what to expect
You can build up to the right dose of Qelbree in as soon as 1-2 weeks. Dosing is a journey, stick with it!
Building to an effective dose takes time
The dose of Qelbree may be adjusted weekly as needed to optimize control of your ADHD symptoms.*
Your healthcare provider will typically start you on a lower dose and increase it gradually over the first 1-2 weeks until you reach the dose that’s right for you, adjusting as needed.
This could be anywhere from 200 mg to 600 mg/day for adults. This process is called titration.
*Your healthcare provider will determine the dose based on your response to medication.
If you have tried other ADHD medications, you may have a different experience with Qelbree. It could take a few weeks for your medication to feel fully effective.
It’s important to know:
Taking a week-by-week approach can help you with starting Qelbree
Managing your ADHD is a journey. Here are some things you can do each week to help with your Qelbree experience when starting out.
It is important to keep all follow-up visits with your healthcare provider and to monitor mood or behavior changes as well as any other side effects while taking Qelbree.
Like many ADHD medications, reaching your best daily dose of Qelbree may take some time. Make sure you stick with your treatment, and check in with your healthcare provider about your progress.
If you’re struggling with symptoms or experiencing side effects, let your healthcare provider know. Sometimes, even small adjustments to your treatment dose can make a big difference.
Use the Qelbree Progress Tracker to help keep track of your experience as you find the right dose of Qelbree.
When I started Qelbree, the cloud lifted.”
Are you switching from another ADHD treatment? It’s common.
Your healthcare provider will advise on what your individualized treatment plan looks like.
Of the children, teens, and adults who switched to Qelbree:
switched to Qelbree from a controlled substance or stimulant medication
switched to Qelbree from other non-stimulant ADHD meds
Starting with Qelbree
Starting with Qelbree
Learn what to expect when starting non-stimulant once-daily Qelbree and why it may be the right treatment option for you.
Convenient refills, including via telehealth
Adults build up to the right dose in as soon as 2 weeks
- The recommended starting dose for adults is 200 mg once daily
- The maximum recommended dosage for adults is 600 mg once daily
Your healthcare provider may gradually increase your dose over 1-2 weeks until you reach the dose that’s right for you. This process is called titration.
The Qelbree capsule can be swallowed whole, or the capsule can be opened and its entire contents sprinkled onto a spoonful of applesauce or pudding.* Do not cut, crush, or chew the capsules.
Qelbree is the only non-stimulant ADHD treatment that can be sprinkled for easier dosing for people who are unable to swallow capsules.
*Once added to applesauce, Qelbree should be all consumed, without chewing, within 2 hours. Once added to pudding, Qelbree should be all consumed, without chewing, within 15 minutes. Do not store for future use.
I can take Qelbree at night and it covers me for the full 24 hours.”
Get your personalized Discussion Guide (Adults)
Get your personalized Discussion Guide
Answer 5-6 questions regarding your ADHD symptoms or treatment experience to create a free Discussion Guide to use at your next appointment.
Adults: Safety and Side Effects
Qelbree is proven to be safe* for adults, with manageable side effects when taken as directed
*Important: Those taking Qelbree should be monitored for mood or behavior changes. The healthcare provider should also monitor for changes in blood pressure and heart rate.
Safe* and effective treatment for ADHD
Summary of these results:
Qelbree is not a controlled substance, and there was no evidence of abuse
Qelbree is unlikely to have any negative interactions with methylphenidate and amphetamine stimulant formulations.
Most common side effects
| Side effect | Placebo | Qelbree |
|---|---|---|
| Trouble sleeping† | 7% | 23% |
| Headache‡ | 7% | 17% |
| Tiredness | 3% | 12% |
| Nausea | 3% | 12% |
| Decreased appetite | 3% | 10% |
| Dry mouth | 2% | 10% |
| Sleepiness (somnolence)§ | 2% | 6% |
| Constipation | 1% | 6% |
†Trouble sleeping: initial insomnia, insomnia, middle insomnia, poor-quality sleep, sleep disorder, terminal insomnia.
‡Headache: headache, migraine, migraine with aura, tension headache.
§Somnolence: somnolence, lethargy, sedation.
9% of participants taking Qelbree discontinued the medical study due to side effects, whereas 5% of those taking the placebo discontinued the study.
Talk to your healthcare provider
Get the Qelbree Savings Card
Frequently asked questions
Results with Qelbree in adults
Results with Qelbree in adults
Qelbree medical study results in adults
Rapid and extended release and full-day coverage
How we ran the study: Qelbree was studied in adults 18-65 years who had been diagnosed with ADHD. The medical study measured what kind of changes in ADHD symptoms these adults experienced over the course of the 6-week study. They measured the frequency and severity of ADHD symptoms, including inattention, hyperactivity, and impulsivity.
Qelbree showed significant reduction in symptom scores compared to placebo.
- Qelbree was proven to help effectively reduce ADHD symptoms with a once-a-day convenient dose in the medical study.
It’s an easy-to-reference source for:
- Key treatment information on Qelbree
- Helpful tips for managing your ADHD
See safety information and learn about possible side effects of Qelbree from medical studies.
The science of Qelbree
The science of Qelbree
A different approach to ADHD treatment
5+ years of experience
FDA approved in 2021 for patients 6-17 years old with ADHD, and in 2022 for adults with ADHD, Qelbree brings over 5 years of real-world experience.
ADHD differences in women and men
ADHD differences in women and men
While gender can't completely predict someone's ADHD journey, there can be differences in how women and men present their ADHD symptoms, and their typical age of diagnosis.
Experience symptoms of inattentive ADHD, which can be less obvious than hyperactive and impulsive symptoms. These include being disorganized, distracted, overwhelmed, or trouble initiating tasks
Mask or overcompensate for their symptoms, leading to a delayed diagnosis
Get diagnosed in adulthood, despite having dealt with ADHD symptoms since childhood. In fact, most women with ADHD don’t receive an accurate diagnosis until their late 30s or early 40s
Experience fluctuations in the severity of their ADHD symptoms over the course of their hormone cycles
- Being overwhelmed
- Being chronically disorganized
- Exhibiting poor time management/chronic lateness
- Experiencing low self-esteem
- Being unable to manage daily activities/chores
- Finding that making/keeping friendships is difficult
It wasn’t until my own daughter was diagnosed with ADHD that I thought ‘Wait this is totally me.’ I talked to my doctor and I was diagnosed.”
Experience symptoms of hyperactive and impulsive ADHD
Get diagnosed in childhood, as they’re more likely to act out in the classroom or at home
Engage in “externalizing” behavior, or hyperactive/impulsive behaviors directed outwardly toward other people or one’s environment
- Sloppiness or careless mistakes
- Trouble listening
- Forgetting appointments
- Procrastination
- Restlessness
- Disorganization or misplacing things constantly
- Excessive talking
- Inability to contain frustration
Having open conversations about ADHD helps to reduce the stigma and provides an opportunity for individuals to learn from, educate, and empower one another.”
Closing the gap
Pagination
IMPORTANT SAFETY INFORMATION ABOUT QELBREE
Qelbree® (viloxazine extended-release capsules) is a prescription medicine used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and children 6 years and older.
IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.
IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.
You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.
Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.
Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.
Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.
The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Medication Guide, including Boxed Warning.
IMPORTANT SAFETY INFORMATION ABOUT QELBREE
Qelbree® (viloxazine extended-release capsules) is a prescription medicine used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and children 6 years and older.
IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.
IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.
You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.
Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.
Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.
Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.
The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Medication Guide, including Boxed Warning.